Soluble CD40 ligand in asthma patients during allergen challenge

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 12, 2006, Pages 2718-2720

  Kowal, Krzysztof ^a   Pampuch, A ^a,b   Kowal bielecka, O ^a   Iacoviello, L ^b   Bodzenta Lukaszyk, A ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CD40 LIGAND; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR ALPHA; PADGEM PROTEIN; SHORT ACTING DRUG;

ADULT; ALLERGIC ASTHMA; ALLERGY TEST; ARTICLE; BLOOD SAMPLING; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HOUSE DUST ALLERGY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; LUNG FUNCTION; MALE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE ACTIVATION; THROMBOCYTE ACTIVATION; UPREGULATION;

ADULT; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BRONCHIAL PROVOCATION TESTS; CD40 LIGAND; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; P-SELECTIN; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 33750990513     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02206.x     Document Type: Article

References (8)

1. Mehlhop PD, van de Rijn M, Brewer JP, Kisselgof AB, Geha RS, Oettgen HC, Martin TR. CD40L, but not CD40, is required for allergen-induced bronchial hyperresponsiveness in mice. Am J Respir Cell Mol Biol 2000; 23: 646-51.
2. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 1995; 155: 4917-25.
3. Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK, Lederman S, Chess L. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J Leukoc Biol 1995; 58: 209-16.
4. Pampuch A, Kowal K, Bodzenta-Lukaszyk A, Di Castelnuovo A, Chyczewski L, Donati MB, Iacoviello L. The -675 4G/5G plasminogen activator inhibitor promoter polymorphism in house dust mite allergic asthma patients. Allergy 2006; 61: 234-8.
5. Kowal K, Pampuch A, Kowal-Bielecka O, Du Buske LM, Bodzenta-Lukaszyk A. Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus. Clin Exp Allergy 2006; 36: 426-32.
6. Angelico F, Alessandri C, Ferro D, Pignatelli P, Del Ben M, Fiorello S, Cangemi R, Loffredo L, Violi F. Enhanced soluble CD40L in patients with the metabolic syndrome: Relationship with in vivo thrombin generation. Diabetologia 2006; 49: 1169-74.
7. Kamath S, Blann AD, Lip GY. Platelet activation: Assessment and quantification. Eur Heart J 2001; 22: 1561-71.
8. Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003; 52: 1435-41.